FBRX
Price
$14.53
Change
-$1.47 (-9.19%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
93.47M
XCUR
Price
$8.62
Change
+$0.72 (+9.11%)
Updated
Jan 14 closing price
Capitalization
26.2M
Ad is loading...

FBRX vs XCUR

Header iconFBRX vs XCUR Comparison
Open Charts FBRX vs XCURBanner chart's image
Forte Biosciences
Price$14.53
Change-$1.47 (-9.19%)
Volume$1.96K
Capitalization93.47M
Exicure
Price$8.62
Change+$0.72 (+9.11%)
Volume$22.16K
Capitalization26.2M
FBRX vs XCUR Comparison Chart
Loading...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBRX vs. XCUR commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBRX is a Hold and XCUR is a Buy.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (FBRX: $14.62 vs. XCUR: $8.62)
Brand notoriety: FBRX and XCUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBRX: 6% vs. XCUR: 2%
Market capitalization -- FBRX: $93.47M vs. XCUR: $26.2M
FBRX [@Biotechnology] is valued at $93.47M. XCUR’s [@Biotechnology] market capitalization is $26.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBRX’s FA Score shows that 0 FA rating(s) are green whileXCUR’s FA Score has 0 green FA rating(s).

  • FBRX’s FA Score: 0 green, 5 red.
  • XCUR’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than XCUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBRX’s TA Score shows that 4 TA indicator(s) are bullish while XCUR’s TA Score has 3 bullish TA indicator(s).

  • FBRX’s TA Score: 4 bullish, 3 bearish.
  • XCUR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than XCUR.

Price Growth

FBRX (@Biotechnology) experienced а -29.61% price change this week, while XCUR (@Biotechnology) price change was -6.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

FBRX is expected to report earnings on Nov 15, 2024.

XCUR is expected to report earnings on Aug 13, 2024.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBRX($93.5M) has a higher market cap than XCUR($26.2M). FBRX (-35.623) and XCUR (-36.942) have similar YTD gains . XCUR has higher annual earnings (EBITDA): -3.17M vs. FBRX (-35.6M). FBRX has more cash in the bank: 16.4M vs. XCUR (343K). XCUR has higher revenues than FBRX: XCUR (500K) vs FBRX (0).
FBRXXCURFBRX / XCUR
Capitalization93.5M26.2M357%
EBITDA-35.6M-3.17M1,122%
Gain YTD-35.623-36.94296%
P/E RatioN/A0.19-
Revenue0500K-
Total Cash16.4M343K4,781%
Total DebtN/A6.13M-
FUNDAMENTALS RATINGS
FBRX vs XCUR: Fundamental Ratings
FBRX
XCUR
OUTLOOK RATING
1..100
7374
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3634
P/E GROWTH RATING
1..100
52100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XCUR's Valuation (77) in the null industry is in the same range as FBRX (99). This means that XCUR’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's Profit vs Risk Rating (98) in the null industry is in the same range as XCUR (100). This means that FBRX’s stock grew similarly to XCUR’s over the last 12 months.

FBRX's SMR Rating (99) in the null industry is in the same range as XCUR (99). This means that FBRX’s stock grew similarly to XCUR’s over the last 12 months.

XCUR's Price Growth Rating (34) in the null industry is in the same range as FBRX (36). This means that XCUR’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for XCUR (100). This means that FBRX’s stock grew somewhat faster than XCUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBRXXCUR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
77%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
74%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 7 days ago
82%
Aroon
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGLO0.200.02
+9.14%
theglobe.com, inc.
XIACY21.620.64
+3.05%
Xiaomi Corp.
BTDPY9.880.13
+1.28%
BARRATT REDROW PLC
IZM1.53N/A
N/A
ICZOOM Group
NRILY28.32-0.41
-1.43%
Nomura Research Institute Ltd.

FBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with QSI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-8.63%
QSI - FBRX
40%
Loosely correlated
+5.18%
AXON - FBRX
31%
Poorly correlated
+1.96%
CHRS - FBRX
30%
Poorly correlated
-2.04%
ARRY - FBRX
28%
Poorly correlated
+2.12%
XCUR - FBRX
27%
Poorly correlated
+9.11%
More

XCUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XCUR has been loosely correlated with XFOR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XCUR jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XCUR
1D Price
Change %
XCUR100%
+9.11%
XFOR - XCUR
34%
Loosely correlated
-19.37%
FBRX - XCUR
27%
Poorly correlated
-8.63%
FATE - XCUR
27%
Poorly correlated
-2.71%
ALNY - XCUR
26%
Poorly correlated
-6.88%
NNVC - XCUR
25%
Poorly correlated
-2.48%
More